Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telbivudine in the Third Trimester of Pregnancy to Prevent Mother-to-infant Transmission of HBV

NCT01637844 is registered in ClinicalTrials.gov with Yi-Hua Zhou as lead sponsor.

NCT NCT01637844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01637844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telbivudine in the Third Trimester of Pregnancy to Prevent Mother-to-infant Transmission of HBV
Lead sponsor
Yi-Hua Zhou
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2012
Completion date
October 31, 2014
Enrollment
335 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hbv